naltrexone (Revia)
naltrexone (Revia) is a pharmaceutical drug with 13 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
11
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
13 of 13 finished
0.0%
0 ended early
0
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sertraline for Alcohol Dependence and Depression
Naltrexone for Relapse Prevention
Behavioral Therapy Plus Naltrexone for Alcoholism
Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
Naltrexone Treatment for Alcoholism
Clinical Trials (13)
Sertraline for Alcohol Dependence and Depression
Naltrexone for Relapse Prevention
Behavioral Therapy Plus Naltrexone for Alcoholism
Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (Naltrexone/Nicotine Patch)
Naltrexone Treatment for Alcoholism
Post-Treatment Effects of Naltrexone
COMBINE (Acamprosate/Naltrexone)
Combined Pharmacotherapies for Alcoholism (Naltrexone/Ondansetron)
Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
Sertraline and Naltrexone for Alcohol Dependence
Naltrexone Treatment of Alcohol Dependence
Behavior and Naltrexone Treatment for Alcoholics
Use of Naltrexone in a Clinical Setting
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13